We have recently curated a list of 12 Healthcare Stocks with Noteworthy Insider Buying in 2025, and PACS Group, Inc. is featured among them.
PACS Group, Inc. (NYSE:PACS), a prominent provider in post-acute care, has gained attention this September due to its regulatory hurdles and ongoing operational expansion. Based in Utah, the company manages 316 facilities across 17 states, providing over 32,000 skilled nursing and 2,400 assisted living beds, with a strong commitment to quality care. The majority of its facilities have earned either 4 or 5-star ratings from CMS. Since the second quarter of 2024, PACS has experienced rapid growth, adding 96 new facilities to its operations.
This September, the New York Stock Exchange granted PACS an extension until November 19, 2025, allowing the company additional time to finish its financial statement restatements from early to mid-2024 and to be current with SEC filings. The company is also working with an independent Audit Committee that is looking into past financial issues. In spite of these challenges, the management has indicated robust growth, forecasting record revenues and adjusted EBITDA for the first half of 2025 once the necessary filings are completed. As of June 30, PACS reported an occupancy rate of 88.9%, significantly higher than the industry average of 78%, along with cash reserves amounting to $294.2 million, which is nearly double compared to the end of 2024, making it a noteworthy option among stocks with insider buying.
The month also saw leadership changes, with CFO Derick Apt stepping down following an internal policy investigation. PACS Group, Inc. (NYSE:PACS) has appointed a former CFO as an interim replacement and has also brought in an interim compliance officer to enhance governance and regulatory management.
While we recognize the investment promise that PACS presents, we believe that specific AI stocks may hold greater potential for profit with comparatively lower risk. If you’re in search of a significantly undervalued AI stock that is poised to benefit from Trump-era tariffs and the trend toward onshoring, check out our complimentary report on the best short-term AI stock.
READ NEXT: 30 Stocks That Could Double in 3 Years and 11 Hidden AI Stocks to Acquire NOW
Disclosure: None.
